162 related articles for article (PubMed ID: 27884511)
1. Effects of previous physical training on adriamycin nephropathy and its relationship with endothelial lesions and angiogenesis in the renal cortex.
Faleiros CM; Francescato HD; Papoti M; Chaves L; Silva CG; Costa RS; Coimbra TM
Life Sci; 2017 Jan; 169():43-51. PubMed ID: 27884511
[TBL] [Abstract][Full Text] [Related]
2. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous hydrogen sulfide on renal damage induced by adriamycin injection.
Francescato HD; Marin EC; Cunha Fde Q; Costa RS; Silva CG; Coimbra TM
Arch Toxicol; 2011 Dec; 85(12):1597-606. PubMed ID: 21590344
[TBL] [Abstract][Full Text] [Related]
4. Previous Exercise Effects in Cisplatin-Induced Renal Lesions in Rats.
Francescato HDC; Almeida LF; Reis NG; Faleiros CM; Papoti M; Costa RS; Coimbra TM
Kidney Blood Press Res; 2018; 43(2):582-593. PubMed ID: 29669331
[TBL] [Abstract][Full Text] [Related]
5. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.
Barretti P; Viero RM; Soares VA
Braz J Med Biol Res; 1995 Jan; 28(1):39-50. PubMed ID: 7581027
[TBL] [Abstract][Full Text] [Related]
7. FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression.
Liu Y; Ji Z
J Nephrol; 2012; 25(6):918-25. PubMed ID: 22865594
[TBL] [Abstract][Full Text] [Related]
8. Glomerular endothelial cell injury and damage precedes that of podocytes in adriamycin-induced nephropathy.
Sun YB; Qu X; Zhang X; Caruana G; Bertram JF; Li J
PLoS One; 2013; 8(1):e55027. PubMed ID: 23359116
[TBL] [Abstract][Full Text] [Related]
9. Heparin treatment reduces glomerular injury in rats with adriamycin-induced nephropathy but does not modify tubulointerstitial damage or the renal production of transforming growth factor-beta.
Baroni EA; Costa RS; da Silva CG; Coimbra TM
Nephron; 2000 Mar; 84(3):248-57. PubMed ID: 10720896
[TBL] [Abstract][Full Text] [Related]
10. Tubular cell lesion, albuminuria, and renal albumin handling in rats treated with adriamycin.
Galli LG; Volpini RA; Costa RS; da Silva CG; Coimbra TM
Ren Fail; 2001 Sep; 23(5):693-703. PubMed ID: 11725916
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.
Zoja C; Garcia PB; Rota C; Conti S; Gagliardini E; Corna D; Zanchi C; Bigini P; Benigni A; Remuzzi G; Morigi M
Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1370-81. PubMed ID: 22952284
[TBL] [Abstract][Full Text] [Related]
12. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.
Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ
Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with telmisartan and oxacalcitriol suppresses the progression of murine adriamycin nephropathy.
Jeong KH; Asanuma K; Lydia A; Takagi M; Asao R; Kodama F; Asanuma E; Tomino Y
Nephron; 2015; 129(2):143-54. PubMed ID: 25661164
[TBL] [Abstract][Full Text] [Related]
14. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
[TBL] [Abstract][Full Text] [Related]
15. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.
Kang DH; Yu ES; Yoon KI; Johnson R
Am J Pathol; 2004 Feb; 164(2):679-88. PubMed ID: 14742271
[TBL] [Abstract][Full Text] [Related]
16. Progression of chronic adriamycin nephropathy in leukopenic rats.
Ginevri F; Trivelli A; Mutti A; Bergamaschi E; Fabbretti G; Callea F; Salvidio G; Altieri P; Perfumo F; Ghiggeri GM
Nephron; 1993; 63(1):79-88. PubMed ID: 8446256
[TBL] [Abstract][Full Text] [Related]
17. Sodium bicarbonate treatment reduces renal injury, renal production of transforming growth factor-beta, and urinary transforming growth factor-beta excretion in rats with doxorubicin-induced nephropathy.
Baroni EA; Costa RS; Volpini R; Coimbra TM
Am J Kidney Dis; 1999 Aug; 34(2):328-37. PubMed ID: 10430982
[TBL] [Abstract][Full Text] [Related]
18. Anticubilin antisense RNA ameliorates adriamycin-induced tubulointerstitial injury in experimental rats.
Liu J; Li K; He Y; Zhang J; Wang H; Yang J; Zhan J; Liang H
Am J Med Sci; 2011 Dec; 342(6):494-502. PubMed ID: 22108171
[TBL] [Abstract][Full Text] [Related]
19. CCNU-adriamycin association induces earlier and more severe nephropathy in rats.
Raguenez-Viotte G; Lahoue M; Ducastelle T; Morin JP; Fillastre JP
Arch Toxicol; 1988; 61(4):282-91. PubMed ID: 3377683
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin ameliorates renal lipidosis through the suppression of renal CXCL16 expression in mice with adriamycin-induced nephropathy.
Wang C; Li Q; Zhen J; Xu Y; Sun S
Int J Clin Exp Pathol; 2015; 8(12):15696-707. PubMed ID: 26884839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
